{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:34:41Z","timestamp":1786448081812,"version":"build-2736575974"},"reference-count":189,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,11]]},"DOI":"10.7759\/cureus.114334","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:59:21Z","timestamp":1786445961000},"source":"Crossref","is-referenced-by-count":0,"title":["Recovery-Primed Stimulation: A Proposed Framework for Controlled Triggering of Healing-Related Physiology in Low-Grade Chronic Inflammation"],"prefix":"10.7759","author":[{"given":"Wilfried","family":"Van Moorleghem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Besselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melia","family":"Matuz Velasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego A","family":"Montelongo Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00021.2024","article-title":"Low-grade chronic inflammation: a shared mechanism for chronic diseases","volume":"40","author":"Cifuentes M","year":"2025","unstructured":"Cifuentes M, Verdejo HE, Castro PF, et al.. Low-grade chronic inflammation: a shared mechanism for chronic diseases. Physiology (Bethesda). 2025, 40:4-25. 10.1152\/physiol.00021.2024","journal-title":"Physiology (Bethesda)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and\u00a0frailty","volume":"15","author":"Ferrucci L","year":"2018","unstructured":"Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and\u00a0frailty. Nat Rev Cardiol. 2018, 15:505-22. 10.1038\/s41569-018-0064-2","journal-title":"Nat Rev Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman D","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, et al.. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019, 25:1822-32. 10.1038\/s41591-019-0675-0","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/febs.17227","article-title":"NF\u03baB dynamics-dependent epigenetic changes modulate inflammatory gene expression and induce cellular senescence","volume":"291","author":"Tabata S","year":"2024","unstructured":"Tabata S, Matsuda K, Soeda S, et al.. NF\u03baB dynamics-dependent epigenetic changes modulate inflammatory gene expression and induce cellular senescence. FEBS J. 2024, 291:4951-68. 10.1111\/febs.17227","journal-title":"FEBS J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi C","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018, 14:576-90. 10.1038\/s41574-018-0059-4","journal-title":"Nat Rev Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-025-00888-0","article-title":"Nonuniversality of inflammaging across human populations","volume":"5","author":"Franck M","year":"2025","unstructured":"Franck M, Tanner KT, Tennyson RL, et al.. Nonuniversality of inflammaging across human populations. Nat Aging. 2025, 5:1471-80. 10.1038\/s43587-025-00888-0","journal-title":"Nat Aging"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/biology11030372","article-title":"NF-\u03baB signaling and inflammation-drug repurposing to treat inflammatory disorders?","volume":"11","author":"Roberti A","year":"2022","unstructured":"Roberti A, Chaffey LE, Greaves DR. NF-\u03baB signaling and inflammation-drug repurposing to treat inflammatory disorders?. Biology (Basel). 2022, 11:10.3390\/biology11030372","journal-title":"Biology (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2015.11.011","article-title":"Small molecules with anti-inflammatory properties in clinical development","volume":"157","author":"Hanke T","year":"2016","unstructured":"Hanke T, Merk D, Steinhilber D, Geisslinger G, Schubert-Zsilavecz M. Small molecules with anti-inflammatory properties in clinical development. Pharmacol Ther. 2016, 157:163-87. 10.1016\/j.pharmthera.2015.11.011","journal-title":"Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106947","article-title":"Drug repurposing and cytokine management in response to COVID-19: a review","volume":"88","author":"Heimfarth L","year":"2020","unstructured":"Heimfarth L, Serafini MR, Martins-Filho PR, Quintans JS, Quintans-J\u00fanior LJ. Drug repurposing and cytokine management in response to COVID-19: a review. Int Immunopharmacol. 2020, 88:106947. 10.1016\/j.intimp.2020.106947","journal-title":"Int Immunopharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R800032200","article-title":"A20: central gatekeeper in inflammation and immunity","volume":"284","author":"Coornaert B","year":"2009","unstructured":"Coornaert B, Carpentier I, Beyaert R. A20: central gatekeeper in inflammation and immunity. J Biol Chem. 2009, 284:8217-21. 10.1074\/jbc.R800032200","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley N","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019, 20:10.3390\/ijms20133328","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.46","article-title":"CYLD, A20 and OTULIN deubiquitinases in NF-\u03baB signaling and cell death: so similar, yet so different","volume":"24","author":"Lork M","year":"2017","unstructured":"Lork M, Verhelst K, Beyaert R. CYLD, A20 and OTULIN deubiquitinases in NF-\u03baB signaling and cell death: so similar, yet so different. Cell Death Differ. 2017, 24:1172-83. 10.1038\/cdd.2017.46","journal-title":"Cell Death Differ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson KV","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019, 19:477-89. 10.1038\/s41577-019-0165-0","journal-title":"Nat Rev Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.43.100901.140223","article-title":"Hormesis: the dose-response revolution","volume":"43","author":"Calabrese EJ","year":"2003","unstructured":"Calabrese EJ, Baldwin LA. Hormesis: the dose-response revolution. Annu Rev Pharmacol Toxicol. 2003, 43:175-97. 10.1146\/annurev.pharmtox.43.100901.140223","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2009.10.002","article-title":"Allostatic load biomarkers of chronic stress and impact on health and cognition","volume":"35","author":"Juster RP","year":"2010","unstructured":"Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2010, 35:2-16. 10.1016\/j.neubiorev.2009.10.002","journal-title":"Neurosci Biobehav Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2010.522281","article-title":"Control of NF-\u03baB and inflammation by the unfolded protein response","volume":"30","author":"Kitamura M","year":"2011","unstructured":"Kitamura M. Control of NF-\u03baB and inflammation by the unfolded protein response. Int Rev Immunol. 2011, 30:4-15. 10.3109\/08830185.2010.522281","journal-title":"Int Rev Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00051.2002","article-title":"Arterial baroreflex function and cardiovascular variability: interactions and implications","volume":"283","author":"Lanfranchi PA","year":"2002","unstructured":"Lanfranchi PA, Somers VK. Arterial baroreflex function and cardiovascular variability: interactions and implications. Am J Physiol Regul Integr Comp Physiol. 2002, 283:R815-26. 10.1152\/ajpregu.00051.2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(66)90068-9","article-title":"Physiological properties of unmyelinated fiber projection to the spinal cord","volume":"16","author":"Mendell LM","year":"1966","unstructured":"Mendell LM. Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol. 1966, 16:316-32. 10.1016\/0014-4886(66)90068-9","journal-title":"Exp Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil MC","year":"2016","unstructured":"Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol. 2016, 16:51-67. 10.1038\/nri.2015.4","journal-title":"Nat Rev Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101605","article-title":"Specialized pro-resolving mediators as modulators of immune responses","volume":"59","author":"Julliard WA","year":"2022","unstructured":"Julliard WA, Myo YP, Perelas A, Jackson PD, Thatcher TH, Sime PJ. Specialized pro-resolving mediators as modulators of immune responses. Semin Immunol. 2022, 59:101605. 10.1016\/j.smim.2022.101605","journal-title":"Semin Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110767","article-title":"Promising application of pulsed electromagnetic fields (PEMFs) in musculoskeletal disorders","volume":"131","author":"Hu H","year":"2020","unstructured":"Hu H, Yang W, Zeng Q, et al.. Promising application of pulsed electromagnetic fields (PEMFs) in musculoskeletal disorders. Biomed Pharmacother. 2020, 131:110767. 10.1016\/j.biopha.2020.110767","journal-title":"Biomed Pharmacother"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10383","article-title":"Recent progress in the manipulation of biochemical and biophysical cues for engineering functional tissues","volume":"8","author":"Bakhshandeh B","year":"2023","unstructured":"Bakhshandeh B, Ranjbar N, Abbasi A, et al.. Recent progress in the manipulation of biochemical and biophysical cues for engineering functional tissues. Bioeng Transl Med. 2023, 8:e10383. 10.1002\/btm2.10383","journal-title":"Bioeng Transl Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.790050","article-title":"Biophysical stimuli as the fourth pillar of bone tissue engineering","volume":"9","author":"Hao Z","year":"2021","unstructured":"Hao Z, Xu Z, Wang X, et al.. Biophysical stimuli as the fourth pillar of bone tissue engineering. Front Cell Dev Biol. 2021, 9:790050. 10.3389\/fcell.2021.790050","journal-title":"Front Cell Dev Biol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706468","article-title":"Pharmacology of intracellular signalling pathways","volume":"147","author":"Nahorski SR","year":"2006","unstructured":"Nahorski SR. Pharmacology of intracellular signalling pathways. Br J Pharmacol. 2006, 147:S38-45. 10.1038\/sj.bjp.0706468","journal-title":"Br J Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2597","article-title":"Mechanotransduction gone awry","volume":"10","author":"Jaalouk DE","year":"2009","unstructured":"Jaalouk DE, Lammerding J. Mechanotransduction gone awry. Nat Rev Mol Cell Biol. 2009, 10:63-73. 10.1038\/nrm2597","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03303-w","article-title":"Electromagnetic fields regulate calcium-mediated cell fate of stem cells: osteogenesis, chondrogenesis and apoptosis","volume":"14","author":"Ma T","year":"2023","unstructured":"Ma T, Ding Q, Liu C, Wu H. Electromagnetic fields regulate calcium-mediated cell fate of stem cells: osteogenesis, chondrogenesis and apoptosis. Stem Cell Res Ther. 2023, 14:133. 10.1186\/s13287-023-03303-w","journal-title":"Stem Cell Res Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/foods13193058","article-title":"A review of electromagnetic fields in cellular interactions and cacao bean fermentation","volume":"13","author":"Guzm\u00e1n-Armenteros TM","year":"2024","unstructured":"Guzm\u00e1n-Armenteros TM, Ruales J, Ramos-Guerrero L. A review of electromagnetic fields in cellular interactions and cacao bean fermentation. Foods. 2024, 13:10.3390\/foods13193058","journal-title":"Foods"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27020694","article-title":"Exercise-based mechanotherapy: from biomechanical principles and mechanotransduction to precision regenerative rehabilitation","volume":"27","author":"Jin GZ","year":"2026","unstructured":"Jin GZ. Exercise-based mechanotherapy: from biomechanical principles and mechanotransduction to precision regenerative rehabilitation. Int J Mol Sci. 2026, 27:10.3390\/ijms27020694","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-026-06138-9","article-title":"All-atom simulations reveal distinct pathways for \u03b1(IIb)\u03b2(3) activation by biochemical vs. mechanical cues","volume":"83","author":"Kolasangiani R","year":"2026","unstructured":"Kolasangiani R, Joshi O, Schwartz MA, Bidone TC. All-atom simulations reveal distinct pathways for \u03b1(IIb)\u03b2(3) activation by biochemical vs. mechanical cues. Cell Mol Life Sci. 2026, 83:10.1007\/s00018-026-06138-9","journal-title":"Cell Mol Life Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-018-4274-3","article-title":"Biophysical stimulation of bone and cartilage: state of the art and future perspectives","volume":"43","author":"Massari L","year":"2019","unstructured":"Massari L, Benazzo F, Falez F, et al.. Biophysical stimulation of bone and cartilage: state of the art and future perspectives. Int Orthop. 2019, 43:539-51. 10.1007\/s00264-018-4274-3","journal-title":"Int Orthop"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.61132\/obat.v3i4.1531","article-title":"Recent advances in biochemical pathways: implication for drug development and therapeutics: a review","volume":"3","author":"Anwer MI","year":"2025","unstructured":"Anwer MI, Khalaf NT, Kamal HR, Abdalmawjood SA. Recent advances in biochemical pathways: implication for drug development and therapeutics: a review. JPM. 2025, 3:340-62. 10.61132\/obat.v3i4.1531","journal-title":"JPM"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1982.03320300027017","article-title":"Pulsing electromagnetic field treatment in ununited fractures and failed arthrodeses","volume":"247","author":"Bassett CA","year":"1982","unstructured":"Bassett CA, Mitchell SN, Gaston SR. Pulsing electromagnetic field treatment in ununited fractures and failed arthrodeses. JAMA. 1982, 247:623-8.","journal-title":"JAMA"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00421-007-0520-x","article-title":"Short-term effects of pulsed electromagnetic fields after physical exercise are dependent on autonomic tone before exposure","volume":"101","author":"Grote V","year":"2007","unstructured":"Grote V, Lackner H, Kelz C, Trapp M, Aichinger F, Puff H, Moser M. Short-term effects of pulsed electromagnetic fields after physical exercise are dependent on autonomic tone before exposure. Eur J Appl Physiol. 2007, 101:495-502. 10.1007\/s00421-007-0520-x","journal-title":"Eur J Appl Physiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.01.065","article-title":"The effect of alpha-lipoic acid on inflammatory mediators: a systematic review and meta-analysis on randomized clinical trials","volume":"849","author":"Haghighatdoost F","year":"2019","unstructured":"Haghighatdoost F, Hariri M. The effect of alpha-lipoic acid on inflammatory mediators: a systematic review and meta-analysis on randomized clinical trials. Eur J Pharmacol. 2019, 849:115-23. 10.1016\/j.ejphar.2019.01.065","journal-title":"Eur J Pharmacol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb09546.x","article-title":"Stress, adaptation, and disease. Allostasis and allostatic load","volume":"840","author":"McEwen BS","year":"1998","unstructured":"McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998, 840:33-44. 10.1111\/j.1749-6632.1998.tb09546.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1159\/000550646","article-title":"Dental caries and systemic inflammation in adolescents: findings from a population-based study","author":"Arouche Costa S","year":"2026","unstructured":"Arouche Costa S, Ribeiro CC, Carneiro AL, Cintra LT\u00c2, Alves CM, Thomaz \u00c9BA, Souza SF. Dental caries and systemic inflammation in adolescents: findings from a population-based study. Caries Res. 2026, 1-8. 10.1159\/000550646","journal-title":"Caries Res"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.06.049","article-title":"The cost of inflammatory bowel disease care: how to make it sustainable","volume":"23","author":"Burisch J","year":"2025","unstructured":"Burisch J, Claytor J, Hernandez I, Hou JK, Kaplan GG. The cost of inflammatory bowel disease care: how to make it sustainable. Clin Gastroenterol Hepatol. 2025, 23:386-95. 10.1016\/j.cgh.2024.06.049","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-103374","article-title":"Inflammatory bowel diseases (IBDs): a cross-sectional analysis of the psychological and biological mechanisms underlying intestinal and extra-intestinal symptoms-GastroPsy study protocol","volume":"15","author":"Caruso A","year":"2025","unstructured":"Caruso A, Latella G, Di Giacomo D, Cavicchioli M, Galli F. Inflammatory bowel diseases (IBDs): a cross-sectional analysis of the psychological and biological mechanisms underlying intestinal and extra-intestinal symptoms-GastroPsy study protocol. BMJ Open. 2025, 15:e103374. 10.1136\/bmjopen-2025-103374","journal-title":"BMJ Open"},{"key":"ref39","unstructured":"Centers for Disease Control and Prevention. health and economic benefits of oral disease interventions. (2024). https:\/\/www.cdc.gov\/nccdphp\/priorities\/oral-disease.html."},{"key":"ref40","unstructured":"Centers for Disease Control and Prevention. fast facts: health and economic costs of chronic conditions. (2026). https:\/\/www.cdc.gov\/chronic-disease\/data-research\/facts-stats\/index.html."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1656","article-title":"Inflammation, insulin resistance, and type 2 diabetes: back to the future?","volume":"58","author":"Cefalu WT","year":"2009","unstructured":"Cefalu WT. Inflammation, insulin resistance, and type 2 diabetes: back to the future?. Diabetes. 2009, 58:307-8. 10.2337\/db08-1656","journal-title":"Diabetes"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-20652-0","article-title":"Inequalities in oral health: estimating the longitudinal economic burden of dental caries by deprivation status in six countries","volume":"24","author":"Dunleavy G","year":"2024","unstructured":"Dunleavy G, Verma N, Raghupathy R, et al.. Inequalities in oral health: estimating the longitudinal economic burden of dental caries by deprivation status in six countries. BMC Public Health. 2024, 24:3239. 10.1186\/s12889-024-20652-0","journal-title":"BMC Public Health"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02031","article-title":"Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based","volume":"9","author":"Fioranelli M","year":"2018","unstructured":"Fioranelli M, Bottaccioli AG, Bottaccioli F, Bianchi M, Rovesti M, Roccia MG. Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based. Front Immunol. 2018, 9:2031. 10.3389\/fimmu.2018.02031","journal-title":"Front Immunol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan D","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011, 144:646-74. 10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka MT","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, et al.. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015, 14:388-405. 10.1016\/S1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil GS","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006, 444:860-7. 10.1038\/nature05485","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121581","article-title":"The role of inflammation in CKD","volume":"12","author":"Kadatane SP","year":"2023","unstructured":"Kadatane SP, Satariano M, Massey M, Mongan K, Raina R. The role of inflammation in CKD. Cells. 2023, 12:10.3390\/cells12121581","journal-title":"Cells"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili K","year":"2021","unstructured":"Pafili K, Roden M. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. Mol Metab. 2021, 50:101122. 10.1016\/j.molmet.2020.101122","journal-title":"Mol Metab"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson WH","year":"2016","unstructured":"Robinson WH, Lepus CM, Wang Q, Raghu H, Mao R, Lindstrom TM, Sokolove J. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016, 12:580-92. 10.1038\/nrrheum.2016.136","journal-title":"Nat Rev Rheumatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09321-0","article-title":"Is Parkinson's disease a chronic low-grade inflammatory bowel disease?","volume":"267","author":"Rolli-Derkinderen M","year":"2020","unstructured":"Rolli-Derkinderen M, Leclair-Visonneau L, Bourreille A, Coron E, Neunlist M, Derkinderen P. Is Parkinson's disease a chronic low-grade inflammatory bowel disease?. J Neurol. 2020, 267:2207-13. 10.1007\/s00415-019-09321-0","journal-title":"J Neurol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-020-0117-1","article-title":"Current and projected future economic burden of Parkinson's disease in the U.S","volume":"6","author":"Yang W","year":"2020","unstructured":"Yang W, Hamilton JL, Kopil C, et al.. Current and projected future economic burden of Parkinson's disease in the U.S. NPJ Parkinsons Dis. 2020, 6:15. 10.1038\/s41531-020-0117-1","journal-title":"NPJ Parkinsons Dis"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Blissett D, Blissett R, et al.. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016, 64:1577-86. 10.1002\/hep.28785","journal-title":"Hepatology"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-22-0271","article-title":"Immunology of chronic low-grade inflammation: relationship with metabolic function","volume":"257","author":"van de Vyver M","year":"2023","unstructured":"van de Vyver M. Immunology of chronic low-grade inflammation: relationship with metabolic function. J Endocrinol. 2023, 257:10.1530\/JOE-22-0271","journal-title":"J Endocrinol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind FG","year":"2009","unstructured":"Bauernfeind FG, Horvath G, Stutz A, et al.. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009, 183:787-91. 10.4049\/jimmunol.0901363","journal-title":"J Immunol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea MG","year":"2016","unstructured":"Netea MG, Joosten LA, Latz E, et al.. Trained immunity: a program of innate immune memory in health and disease. Science. 2016, 352:aaf1098. 10.1126\/science.aaf1098","journal-title":"Science"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1159\/000510696","article-title":"Allostatic load and its impact on health: a systematic review","volume":"90","author":"Guidi J","year":"2021","unstructured":"Guidi J, Lucente M, Sonino N, Fava GA. Allostatic load and its impact on health: a systematic review. Psychother Psychosom. 2021, 90:11-27. 10.1159\/000510696","journal-title":"Psychother Psychosom"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.620392","article-title":"The threshold effect: lipopolysaccharide-induced inflammatory responses in primary macrophages are differentially regulated in an iRhom2-dependent manner","volume":"10","author":"Skurski J","year":"2020","unstructured":"Skurski J, Dixit G, Blobel CP, Issuree PD, Maretzky T. The threshold effect: lipopolysaccharide-induced inflammatory responses in primary macrophages are differentially regulated in an iRhom2-dependent manner. Front Cell Infect Microbiol. 2020, 10:620392. 10.3389\/fcimb.2020.620392","journal-title":"Front Cell Infect Microbiol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302351","article-title":"I\u03baB\u03b5 is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner","volume":"192","author":"Alves BN","year":"2014","unstructured":"Alves BN, Tsui R, Almaden J, et al.. I\u03baB\u03b5 is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner. J Immunol. 2014, 192:3121-32. 10.4049\/jimmunol.1302351","journal-title":"J Immunol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200510155","article-title":"I\u03baB\u03b5 provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression","volume":"173","author":"Kearns JD","year":"2006","unstructured":"Kearns JD, Basak S, Werner SL, Huang CS, Hoffmann A. I\u03baB\u03b5 provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression. J Cell Biol. 2006, 173:659-64. 10.1083\/jcb.200510155","journal-title":"J Cell Biol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2613.2006.00507.x","article-title":"Chronic inflammation: a failure of resolution?","volume":"88","author":"Lawrence T","year":"2007","unstructured":"Lawrence T, Gilroy DW. Chronic inflammation: a failure of resolution?. Int J Exp Pathol. 2007, 88:85-94. 10.1111\/j.1365-2613.2006.00507.x","journal-title":"Int J Exp Pathol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1600149","article-title":"Molecular dynamics of inflammation resolution: therapeutic implications","volume":"13","author":"Soliman AM","year":"2025","unstructured":"Soliman AM, Soliman M, Shah SS, et al.. Molecular dynamics of inflammation resolution: therapeutic implications. Front Cell Dev Biol. 2025, 13:1600149. 10.3389\/fcell.2025.1600149","journal-title":"Front Cell Dev Biol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00160","article-title":"Resolution of inflammation: what controls its onset?","volume":"7","author":"Sugimoto MA","year":"2016","unstructured":"Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. Resolution of inflammation: what controls its onset?. Front Immunol. 2016, 7:160. 10.3389\/fimmu.2016.00160","journal-title":"Front Immunol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng CN","year":"2007","unstructured":"Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007, 117:175-84. 10.1172\/JCI29881","journal-title":"J Clin Invest"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101755","article-title":"Chronic inflammation and the hallmarks of aging","volume":"74","author":"Baechle JJ","year":"2023","unstructured":"Baechle JJ, Chen N, Makhijani P, Winer S, Furman D, Winer DA. Chronic inflammation and the hallmarks of aging. Mol Metab. 2023, 74:101755. 10.1016\/j.molmet.2023.101755","journal-title":"Mol Metab"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.4161\/gmic.19625","article-title":"Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity","volume":"3","author":"Cani PD","year":"2012","unstructured":"Cani PD, Osto M, Geurts L, Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 2012, 3:279-88. 10.4161\/gmic.19625","journal-title":"Gut Microbes"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3390\/nu12040989","article-title":"Chronic stress contributes to osteosarcopenic adiposity via inflammation and immune modulation: the case for more precise nutritional investigation","volume":"12","author":"Ilich JZ","year":"2020","unstructured":"Ilich JZ, Gilman JC, Cvijetic S, Boschiero D. Chronic stress contributes to osteosarcopenic adiposity via inflammation and immune modulation: the case for more precise nutritional investigation. Nutrients. 2020, 12:10.3390\/nu12040989","journal-title":"Nutrients"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28846-z","article-title":"Differential recognition of canonical NF-\u03baB dimers by Importin \u03b13","volume":"13","author":"Florio TJ","year":"2022","unstructured":"Florio TJ, Lokareddy RK, Yeggoni DP, Sankhala RS, Ott CA, Gillilan RE, Cingolani G. Differential recognition of canonical NF-\u03baB dimers by Importin \u03b13. Nat Commun. 2022, 13:1207. 10.1038\/s41467-022-28846-z","journal-title":"Nat Commun"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu T","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017, 2:17023. 10.1038\/sigtrans.2017.23","journal-title":"Signal Transduct Target Ther"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1038\/nm1201-1291","article-title":"Possible new role for NF-kappaB in the resolution of inflammation","volume":"7","author":"Lawrence T","year":"2001","unstructured":"Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med. 2001, 7:1291-7. 10.1038\/nm1201-1291","journal-title":"Nat Med"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2008.73","article-title":"NF-kappaB dictates the degradation pathway of I\u03baB\u03b1","volume":"27","author":"Mathes E","year":"2008","unstructured":"Mathes E, O'Dea EL, Hoffmann A, Ghosh G. NF-kappaB dictates the degradation pathway of I\u03baB\u03b1. EMBO J. 2008, 27:1357-67. 10.1038\/emboj.2008.73","journal-title":"EMBO J"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1038\/msb4100148","article-title":"A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity","volume":"3","author":"O'Dea EL","year":"2007","unstructured":"O'Dea EL, Barken D, Peralta RQ, et al.. A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity. Mol Syst Biol. 2007, 3:111. 10.1038\/msb4100148","journal-title":"Mol Syst Biol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20210139","article-title":"Inhibitory feedback control of NF-\u03baB signalling in health and disease","volume":"478","author":"Prescott JA","year":"2021","unstructured":"Prescott JA, Mitchell JP, Cook SJ. Inhibitory feedback control of NF-\u03baB signalling in health and disease. Biochem J. 2021, 478:2619-64. 10.1042\/BCJ20210139","journal-title":"Biochem J"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2010.171","article-title":"Structural studies of NF-\u03baB signaling","volume":"21","author":"Zheng C","year":"2011","unstructured":"Zheng C, Yin Q, Wu H. Structural studies of NF-\u03baB signaling. Cell Res. 2011, 21:183-95. 10.1038\/cr.2010.171","journal-title":"Cell Res"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s44466-025-00014-0","article-title":"NF-\u03baB: master regulator of cellular responses in health and disease","volume":"1","author":"Hoffmann A","year":"2025","unstructured":"Hoffmann A, Cheng G, Baltimore D. NF-\u03baB: master regulator of cellular responses in health and disease. Immun Inflamm. 2025, 1:2. 10.1007\/s44466-025-00014-0","journal-title":"Immun Inflamm"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.3.1014","article-title":"A nuclear export signal in the N-terminal regulatory domain of I\u03baB\u03b1 controls cytoplasmic localization of inactive NF-\u03baB\/I\u03baB\u03b1 complexes","volume":"97","author":"Huang TT","year":"2000","unstructured":"Huang TT, Kudo N, Yoshida M, Miyamoto S. A nuclear export signal in the N-terminal regulatory domain of I\u03baB\u03b1 controls cytoplasmic localization of inactive NF-\u03baB\/I\u03baB\u03b1 complexes. Proc Natl Acad Sci U S A. 2000, 97:1014-9. 10.1073\/pnas.97.3.1014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1002\/embr.201337983","article-title":"The I\u03baB kinase complex in NF-\u03baB regulation and beyond","volume":"15","author":"Hinz M","year":"2014","unstructured":"Hinz M, Scheidereit C. The I\u03baB kinase complex in NF-\u03baB regulation and beyond. EMBO Rep. 2014, 15:46-61. 10.1002\/embr.201337983","journal-title":"EMBO Rep"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113858","article-title":"Relevance of SIRT1-NF-\u03baB axis as therapeutic target to ameliorate inflammation in liver disease","volume":"21","author":"de Gregorio E","year":"2020","unstructured":"de Gregorio E, Colell A, Morales A, Mar\u00ed M. Relevance of SIRT1-NF-\u03baB axis as therapeutic target to ameliorate inflammation in liver disease. Int J Mol Sci. 2020, 21:10.3390\/ijms21113858","journal-title":"Int J Mol Sci"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.612796","article-title":"Ubiquitinated sirtuin 1 (SIRT1) function is modulated during DNA damage-induced cell death and survival","volume":"290","author":"Peng L","year":"2015","unstructured":"Peng L, Yuan Z, Li Y, et al.. Ubiquitinated sirtuin 1 (SIRT1) function is modulated during DNA damage-induced cell death and survival. J Biol Chem. 2015, 290:8904-12. 10.1074\/jbc.M114.612796","journal-title":"J Biol Chem"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046364","article-title":"SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-\u03baB activity","volume":"7","author":"Yang H","year":"2012","unstructured":"Yang H, Zhang W, Pan H, et al.. SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-\u03baB activity. PLoS One. 2012, 7:e46364. 10.1371\/journal.pone.0046364","journal-title":"PLoS One"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.831168","article-title":"Regulation of SIRT1 and its roles in inflammation","volume":"13","author":"Yang Y","year":"2022","unstructured":"Yang Y, Liu Y, Wang Y, et al.. Regulation of SIRT1 and its roles in inflammation. Front Immunol. 2022, 13:831168. 10.3389\/fimmu.2022.831168","journal-title":"Front Immunol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010128","article-title":"Cyclic AMP regulates key features of macrophages via PKA: recruitment, reprogramming and efferocytosis","volume":"9","author":"Negreiros-Lima GL","year":"2020","unstructured":"Negreiros-Lima GL, Lima KM, Moreira IZ, et al.. Cyclic AMP regulates key features of macrophages via PKA: recruitment, reprogramming and efferocytosis. Cells. 2020, 9:10.3390\/cells9010128","journal-title":"Cells"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2004.00214.x","article-title":"IL-12 and IL-23: master regulators of innate and adaptive immunity","volume":"202","author":"Langrish CL","year":"2004","unstructured":"Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev. 2004, 202:96-105. 10.1111\/j.0105-2896.2004.00214.x","journal-title":"Immunol Rev"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.10.015","article-title":"Efferocytosis induces macrophage proliferation to help resolve tissue injury","volume":"33","author":"Gerlach BD","year":"2021","unstructured":"Gerlach BD, Ampomah PB, Yurdagul A Jr, et al.. Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metab. 2021, 33:2445-2463.e8. 10.1016\/j.cmet.2021.10.015","journal-title":"Cell Metab"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-023-00921-9","article-title":"Efferocytosis-induced lactate enables the proliferation of pro-resolving macrophages to mediate tissue repair","volume":"5","author":"Ngai D","year":"2023","unstructured":"Ngai D, Schilperoort M, Tabas I. Efferocytosis-induced lactate enables the proliferation of pro-resolving macrophages to mediate tissue repair. Nat Metab. 2023, 5:2206-19. 10.1038\/s42255-023-00921-9","journal-title":"Nat Metab"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02479-2","article-title":"Pulsed electromagnetic fields inhibit atherosclerosis by regulating pyroptosis through membrane tension-mediated mechanosensitive channels","volume":"10","author":"Cheng H","year":"2025","unstructured":"Cheng H, Zhang Q, Zhong W, et al.. Pulsed electromagnetic fields inhibit atherosclerosis by regulating pyroptosis through membrane tension-mediated mechanosensitive channels. Signal Transduct Target Ther. 2025, 10:388. 10.1038\/s41392-025-02479-2","journal-title":"Signal Transduct Target Ther"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6647497","article-title":"Evaluation of pulsed electromagnetic field effects: a systematic review and meta-analysis on highlights of two decades of research in vitro studies","volume":"2021","author":"Mansourian M","year":"2021","unstructured":"Mansourian M, Shanei A. Evaluation of pulsed electromagnetic field effects: a systematic review and meta-analysis on highlights of two decades of research in vitro studies. Biomed Res Int. 2021, 2021:6647497. 10.1155\/2021\/6647497","journal-title":"Biomed Res Int"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.04.056","article-title":"Activation of the JNK pathway by nanosecond pulsed electric fields","volume":"408","author":"Morotomi-Yano K","year":"2011","unstructured":"Morotomi-Yano K, Uemura Y, Katsuki S, Akiyama H, Yano K. Activation of the JNK pathway by nanosecond pulsed electric fields. Biochem Biophys Res Commun. 2011, 408:471-6. 10.1016\/j.bbrc.2011.04.056","journal-title":"Biochem Biophys Res Commun"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1191782","article-title":"The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases","volume":"14","author":"Navarro-Comp\u00e1n V","year":"2023","unstructured":"Navarro-Comp\u00e1n V, Puig L, Vidal S, et al.. The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases. Front Immunol. 2023, 14:1191782. 10.3389\/fimmu.2023.1191782","journal-title":"Front Immunol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28508","article-title":"The IL-23\/IL-17 axis in inflammation","volume":"116","author":"Iwakura Y","year":"2006","unstructured":"Iwakura Y, Ishigame H. The IL-23\/IL-17 axis in inflammation. J Clin Invest. 2006, 116:1218-22. 10.1172\/JCI28508","journal-title":"J Clin Invest"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2005.10.003","article-title":"Understanding the IL-23-IL-17 immune pathway","volume":"27","author":"McKenzie BS","year":"2006","unstructured":"McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 2006, 27:17-23. 10.1016\/j.it.2005.10.003","journal-title":"Trends Immunol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104530","article-title":"Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis","volume":"9","author":"Levine YA","year":"2014","unstructured":"Levine YA, Koopman FA, Faltys M, et al.. Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis. PLoS One. 2014, 9:e104530. 10.1371\/journal.pone.0104530","journal-title":"PLoS One"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.3791\/50765","article-title":"Isolation and th17 differentiation of na\u00efve CD4 T lymphocytes","author":"Bedoya SK","year":"2013","unstructured":"Bedoya SK, Wilson TD, Collins EL, Lau K, Larkin J 3rd. Isolation and th17 differentiation of na\u00efve CD4 T lymphocytes. J Vis Exp. 2013, e50765. 10.3791\/50765","journal-title":"J Vis Exp"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou L","year":"2008","unstructured":"Zhou L, Lopes JE, Chong MM, et al.. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008, 453:236-40. 10.1038\/nature06878","journal-title":"Nature"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo F","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med. 2024, 19:275-93. 10.1007\/s11739-023-03374-w","journal-title":"Intern Emerg Med"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.20510.1","article-title":"All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases","volume":"9","author":"Fasano A","year":"2020","unstructured":"Fasano A. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Res. 2020, 9:10.12688\/f1000research.20510.1","journal-title":"F1000Res"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10030578","article-title":"Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options","volume":"10","author":"Hrncir T","year":"2022","unstructured":"Hrncir T. Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options. Microorganisms. 2022, 10:10.3390\/microorganisms10030578","journal-title":"Microorganisms"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594150","article-title":"Role of metabolic endotoxemia in systemic inflammation and potential interventions","volume":"11","author":"Mohammad S","year":"2020","unstructured":"Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol. 2020, 11:594150. 10.3389\/fimmu.2020.594150","journal-title":"Front Immunol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00704.2025","article-title":"From gut to blood: barrier dysfunction as a driver of systemic low-grade inflammation in cardiometabolic disease","volume":"329","author":"Yang-Jensen SK","year":"2025","unstructured":"Yang-Jensen SK, N\u00e4gele NS, Jensen BA. From gut to blood: barrier dysfunction as a driver of systemic low-grade inflammation in cardiometabolic disease. Am J Physiol Cell Physiol. 2025, 329:C1723-41. 10.1152\/ajpcell.00704.2025","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa Y","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, et al.. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013, 504:446-50. 10.1038\/nature12721","journal-title":"Nature"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.05.028","article-title":"Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease","volume":"37","author":"Hanash AM","year":"2012","unstructured":"Hanash AM, Dudakov JA, Hua G, et al.. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity. 2012, 37:339-50. 10.1016\/j.immuni.2012.05.028","journal-title":"Immunity"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1668173","article-title":"The AhR\/IL-22 axis in chronic gut inflammation: unraveling mechanisms and therapeutic prospects","volume":"16","author":"Kang H","year":"2025","unstructured":"Kang H, Chen Z, Wang B, Chen Z. The AhR\/IL-22 axis in chronic gut inflammation: unraveling mechanisms and therapeutic prospects. Front Immunol. 2025, 16:1668173. 10.3389\/fimmu.2025.1668173","journal-title":"Front Immunol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2011.41","article-title":"Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut","volume":"4","author":"Mantis NJ","year":"2011","unstructured":"Mantis NJ, Rol N, Corth\u00e9sy B. Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011, 4:603-11. 10.1038\/mi.2011.41","journal-title":"Mucosal Immunol"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2021.07.005","article-title":"The production and function of endogenous interleukin-10 in intestinal epithelial cells and gut homeostasis","volume":"12","author":"Nguyen HD","year":"2021","unstructured":"Nguyen HD, Aljamaei HM, Stadnyk AW. The production and function of endogenous interleukin-10 in intestinal epithelial cells and gut homeostasis. Cell Mol Gastroenterol Hepatol. 2021, 12:1343-52. 10.1016\/j.jcmgh.2021.07.005","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/258164","article-title":"The role of TL1A and DR3 in autoimmune and inflammatory diseases","volume":"2013","author":"Aiba Y","year":"2013","unstructured":"Aiba Y, Nakamura M. The role of TL1A and DR3 in autoimmune and inflammatory diseases. Mediators Inflamm. 2013, 2013:258164. 10.1155\/2013\/258164","journal-title":"Mediators Inflamm"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-018-0234-9","article-title":"Immunology of wound healing","volume":"7","author":"Ellis S","year":"2018","unstructured":"Ellis S, Lin EJ, Tartar D. Immunology of wound healing. Curr Dermatol Rep. 2018, 7:350-8. 10.1007\/s13671-018-0234-9","journal-title":"Curr Dermatol Rep"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2268-0","article-title":"Transition from inflammation to proliferation: a critical step during wound healing","volume":"73","author":"Land\u00e9n NX","year":"2016","unstructured":"Land\u00e9n NX, Li D, St\u00e5hle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci. 2016, 73:3861-85. 10.1007\/s00018-016-2268-0","journal-title":"Cell Mol Life Sci"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186964","article-title":"Prolonged immune alteration following resolution of acute inflammation in humans","volume":"12","author":"Motwani MP","year":"2017","unstructured":"Motwani MP, Newson J, Kwong S, Richard-Loendt A, Colas R, Dalli J, Gilroy DW. Prolonged immune alteration following resolution of acute inflammation in humans. PLoS One. 2017, 12:e0186964. 10.1371\/journal.pone.0186964","journal-title":"PLoS One"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010641","article-title":"Acute inflammation in tissue healing","volume":"24","author":"Soliman AM","year":"2022","unstructured":"Soliman AM, Barreda DR. Acute inflammation in tissue healing. Int J Mol Sci. 2022, 24:10.3390\/ijms24010641","journal-title":"Int J Mol Sci"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089375","article-title":"Characterisation of leukocytes in a human skin blister model of acute inflammation and resolution","volume":"9","author":"Jenner W","year":"2014","unstructured":"Jenner W, Motwani M, Veighey K, et al.. Characterisation of leukocytes in a human skin blister model of acute inflammation and resolution. PLoS One. 2014, 9:e89375. 10.1371\/journal.pone.0089375","journal-title":"PLoS One"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1172\/JCI89429","article-title":"Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans","volume":"127","author":"Rathod KS","year":"2017","unstructured":"Rathod KS, Kapil V, Velmurugan S, et al.. Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. J Clin Invest. 2017, 127:169-82. 10.1172\/JCI89429","journal-title":"J Clin Invest"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran AC","year":"2020","unstructured":"Doran AC, Yurdagul A Jr, Tabas I. Efferocytosis in health and disease. Nat Rev Immunol. 2020, 20:254-67. 10.1038\/s41577-019-0240-6","journal-title":"Nat Rev Immunol"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1007\/s12199-009-0118-5","article-title":"Formation of 8-nitroguanine, a nitrative DNA lesion, in inflammation-related carcinogenesis and its significance","volume":"15","author":"Hiraku Y","year":"2010","unstructured":"Hiraku Y. Formation of 8-nitroguanine, a nitrative DNA lesion, in inflammation-related carcinogenesis and its significance. Environ Health Prev Med. 2010, 15:63-72. 10.1007\/s12199-009-0118-5","journal-title":"Environ Health Prev Med"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081808","article-title":"Crosstalk between DNA damage and inflammation in the multiple steps of carcinogenesis","volume":"18","author":"Kawanishi S","year":"2017","unstructured":"Kawanishi S, Ohnishi S, Ma N, Hiraku Y, Murata M. Crosstalk between DNA damage and inflammation in the multiple steps of carcinogenesis. Int J Mol Sci. 2017, 18:10.3390\/ijms18081808","journal-title":"Int J Mol Sci"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.5483\/bmbrep.2016.49.10.115","article-title":"Mitophagy: a balance regulator of NLRP3 inflammasome activation","volume":"49","author":"Kim MJ","year":"2016","unstructured":"Kim MJ, Yoon JH, Ryu JH. Mitophagy: a balance regulator of NLRP3 inflammasome activation. BMB Rep. 2016, 49:529-35. 10.5483\/bmbrep.2016.49.10.115","journal-title":"BMB Rep"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-024-01060-w","article-title":"DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications","volume":"24","author":"Drew Y","year":"2025","unstructured":"Drew Y, Zenke FT, Curtin NJ. DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications. Nat Rev Drug Discov. 2025, 24:19-39. 10.1038\/s41573-024-01060-w","journal-title":"Nat Rev Drug Discov"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan CN","year":"2005","unstructured":"Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005, 6:1191-7. 10.1038\/ni1276","journal-title":"Nat Immunol"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis","volume":"201","author":"Hawkes JE","year":"2018","unstructured":"Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. J Immunol. 2018, 201:1605-13. 10.4049\/jimmunol.1800013","journal-title":"J Immunol"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae208","article-title":"Low-dose colchicine for atherosclerosis: long-term safety","volume":"45","author":"Nidorf SM","year":"2024","unstructured":"Nidorf SM, Ben-Chetrit E, Ridker PM. Low-dose colchicine for atherosclerosis: long-term safety. Eur Heart J. 2024, 45:1596-601. 10.1093\/eurheartj\/ehae208","journal-title":"Eur Heart J"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker PM","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, et al.. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017, 377:1119-31. 10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane JR","year":"1998","unstructured":"Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998, 38:97-120. 10.1146\/annurev.pharmtox.38.1.97","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead625","article-title":"Colchicine: the good, the bad, the ugly and how to minimize the risks","volume":"63","author":"Stamp LK","year":"2024","unstructured":"Stamp LK, Horsley C, Te Karu L, Dalbeth N, Barclay M. Colchicine: the good, the bad, the ugly and how to minimize the risks. Rheumatology (Oxford). 2024, 63:936-44. 10.1093\/rheumatology\/kead625","journal-title":"Rheumatology (Oxford)"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp16X684433","article-title":"The dangers of NSAIDs: look both ways","volume":"66","author":"Davis A","year":"2016","unstructured":"Davis A, Robson J. The dangers of NSAIDs: look both ways. Br J Gen Pract. 2016, 66:172-3. 10.3399\/bjgp16X684433","journal-title":"Br J Gen Pract"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnad016","article-title":"Treating the side effects of exogenous glucocorticoids; can we separate the good from the bad?","volume":"44","author":"Pofi R","year":"2023","unstructured":"Pofi R, Caratti G, Ray DW, Tomlinson JW. Treating the side effects of exogenous glucocorticoids; can we separate the good from the bad?. Endocr Rev. 2023, 44:975-1011. 10.1210\/endrev\/bnad016","journal-title":"Endocr Rev"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008794.pub2","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","volume":"2011","author":"Singh JA","year":"2011","unstructured":"Singh JA, Wells GA, Christensen R, et al.. Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev. 2011, 2011:CD008794. 10.1002\/14651858.CD008794.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2025.2474507","article-title":"Risk of serious infection with JAK inhibitors in immune-mediated inflammatory skin diseases: a meta-analysis of randomized clinical trials","volume":"36","author":"Su X","year":"2025","unstructured":"Su X, Ou Y, Ruan S, Lv X, Qin K, Mao J, Ji C. Risk of serious infection with JAK inhibitors in immune-mediated inflammatory skin diseases: a meta-analysis of randomized clinical trials. J Dermatolog Treat. 2025, 36:2474507. 10.1080\/09546634.2025.2474507","journal-title":"J Dermatolog Treat"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.4110\/in.2023.23.e27","article-title":"NLRP3 exacerbate NETosis-associated neuroinflammation in an LPS-induced inflamed brain","volume":"23","author":"Byun DJ","year":"2023","unstructured":"Byun DJ, Lee J, Yu JW, Hyun YM. NLRP3 exacerbate NETosis-associated neuroinflammation in an LPS-induced inflamed brain. Immune Netw. 2023, 23:e27. 10.4110\/in.2023.23.e27","journal-title":"Immune Netw"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.2174\/0118743064340418241021095046","article-title":"PDE4 inhibitors and their potential combinations for the treatment of chronic obstructive pulmonary disease: a narrative review","volume":"18","author":"Kumar R","year":"2024","unstructured":"Kumar R, Khan MI, Panwar A, Vashist B, Rai SK, Kumar A. PDE4 inhibitors and their potential combinations for the treatment of chronic obstructive pulmonary disease: a narrative review. Open Respir Med J. 2024, 18:e18743064340418. 10.2174\/0118743064340418241021095046","journal-title":"Open Respir Med J"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29518","article-title":"Overview of methotrexate toxicity: a comprehensive literature review","volume":"14","author":"Hamed KM","year":"2022","unstructured":"Hamed KM, Dighriri IM, Baomar AF, et al.. Overview of methotrexate toxicity: a comprehensive literature review. Cureus. 2022, 14:e29518. 10.7759\/cureus.29518","journal-title":"Cureus"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14947","article-title":"Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm(\u00ae) - and placebo-controlled trial (BRIDGE)","volume":"176","author":"Mrowietz U","year":"2017","unstructured":"Mrowietz U, Szepietowski JC, Loewe R, et al.. Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm(\u00ae) - and placebo-controlled trial (BRIDGE). Br J Dermatol. 2017, 176:615-23. 10.1111\/bjd.14947","journal-title":"Br J Dermatol"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-051921-084047","article-title":"Specialized pro-resolving mediators as resolution pharmacology for the control of pain and itch","volume":"63","author":"Ji RR","year":"2023","unstructured":"Ji RR. Specialized pro-resolving mediators as resolution pharmacology for the control of pain and itch. Annu Rev Pharmacol Toxicol. 2023, 63:273-93. 10.1146\/annurev-pharmtox-051921-084047","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1080\/20415990.2025.2570109","article-title":"Optimizing delivery of specialized pro-resolving mediators for oral inflammation via smart hydrogels and biomaterials","volume":"16","author":"Gaudin A","year":"2025","unstructured":"Gaudin A, Tessier S, Guyon L, Peters OA. Optimizing delivery of specialized pro-resolving mediators for oral inflammation via smart hydrogels and biomaterials. Ther Deliv. 2025, 16:975-88. 10.1080\/20415990.2025.2570109","journal-title":"Ther Deliv"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00877-w","article-title":"Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation","volume":"30","author":"Serhan CN","year":"2024","unstructured":"Serhan CN, Chiang N, Nshimiyimana R. Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation. Mol Med. 2024, 30:153. 10.1186\/s10020-024-00877-w","journal-title":"Mol Med"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.17.5335","article-title":"Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes","volume":"81","author":"Serhan CN","year":"1984","unstructured":"Serhan CN, Hamberg M, Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci U S A. 1984, 81:5335-9. 10.1073\/pnas.81.17.5335","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan CN","year":"2000","unstructured":"Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med. 2000, 192:1197-204. 10.1084\/jem.192.8.1197","journal-title":"J Exp Med"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.282836","article-title":"Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial","volume":"311","author":"Nicholls SJ","year":"2014","unstructured":"Nicholls SJ, Kastelein JJ, Schwartz GG, et al.. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA. 2014, 311:252-62. 10.1001\/jama.2013.282836","journal-title":"JAMA"},{"key":"ref136","unstructured":"GlaxoSmithKline. Phase III study with darapladib did not meet primary endpoint in patients following an acute coronary syndrome. (2014). https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/gsk-announces-phase-iii-study-with-darapladib-did-not-meet-primary-end...."},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.11061","article-title":"Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial","volume":"312","author":"O'Donoghue ML","year":"2014","unstructured":"O'Donoghue ML, Braunwald E, White HD, et al.. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA. 2014, 312:1006-15. 10.1001\/jama.2014.11061","journal-title":"JAMA"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2016.08.53","article-title":"Losmapimod does not reduce cardiovascular events in patients with acute myocardial infarction","volume":"8","author":"Aronow WS","year":"2016","unstructured":"Aronow WS, Kaple RK. Losmapimod does not reduce cardiovascular events in patients with acute myocardial infarction. J Thorac Dis. 2016, 8:2328-30. 10.21037\/jtd.2016.08.53","journal-title":"J Thorac Dis"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3609","article-title":"Effect of losmapimod on cardiovascular outcomes in patients hospitalized with acute myocardial infarction: a randomized clinical trial","volume":"315","author":"O'Donoghue ML","year":"2016","unstructured":"O'Donoghue ML, Glaser R, Cavender MA, et al.. Effect of losmapimod on cardiovascular outcomes in patients hospitalized with acute myocardial infarction: a randomized clinical trial. JAMA. 2016, 315:1591-9. 10.1001\/jama.2016.3609","journal-title":"JAMA"},{"key":"ref140","unstructured":"Merck. Merck\u2019s Tulisokibart met primary and key secondary endpoints in the Phase 3 ATLAS-UC induction-only study in patients with moderately to severely active ulcerative colitis. (2026). https:\/\/www.merck.com\/news\/mercks-tulisokibart-met-primary-and-key-secondary-endpoints-in-the-phase-3-atlas-uc-induct...."},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(25)00071-8","article-title":"Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial","volume":"10","author":"Feagan BG","year":"2025","unstructured":"Feagan BG, Sands BE, Siegel CA, et al.. Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial. Lancet Gastroenterol Hepatol. 2025, 10:715-25. 10.1016\/S2468-1253(25)00071-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2005.10.003","article-title":"A review of the use and role of low potencies in homeopathy","volume":"13","author":"J\u00fctte R","year":"2005","unstructured":"J\u00fctte R, Riley D. A review of the use and role of low potencies in homeopathy. Complement Ther Med. 2005, 13:291-6. 10.1016\/j.ctim.2005.10.003","journal-title":"Complement Ther Med"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S118298","article-title":"An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis","volume":"11","author":"Martin-Martin LS","year":"2017","unstructured":"Martin-Martin LS, Giovannangeli F, Bizzi E, Massafra U, Ballanti E, Cassol M, Migliore A. An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis. Drug Des Devel Ther. 2017, 11:985-94. 10.2147\/DDDT.S118298","journal-title":"Drug Des Devel Ther"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2007.08.007","article-title":"Hormesis defined","volume":"7","author":"Mattson MP","year":"2008","unstructured":"Mattson MP. Hormesis defined. Ageing Res Rev. 2008, 7:1-7. 10.1016\/j.arr.2007.08.007","journal-title":"Ageing Res Rev"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114254","article-title":"Therapeutics on the clock: circadian medicine in the treatment of chronic inflammatory diseases","volume":"182","author":"Jacob H","year":"2020","unstructured":"Jacob H, Curtis AM, Kearney CJ. Therapeutics on the clock: circadian medicine in the treatment of chronic inflammatory diseases. Biochem Pharmacol. 2020, 182:114254. 10.1016\/j.bcp.2020.114254","journal-title":"Biochem Pharmacol"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000256","article-title":"Dose and timing in neurorehabilitation: prescribing motor therapy after stroke","volume":"28","author":"Lang CE","year":"2015","unstructured":"Lang CE, Lohse KR, Birkenmeier RL. Dose and timing in neurorehabilitation: prescribing motor therapy after stroke. Curr Opin Neurol. 2015, 28:549-55. 10.1097\/WCO.0000000000000256","journal-title":"Curr Opin Neurol"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.5114\/jhk\/186659","article-title":"The importance of recovery in resistance training microcycle construction","volume":"91","author":"Sousa CA","year":"2024","unstructured":"Sousa CA, Zourdos MC, Storey AG, Helms ER. The importance of recovery in resistance training microcycle construction. J Hum Kinet. 2024, 91:205-23. 10.5114\/jhk\/186659","journal-title":"J Hum Kinet"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.31","article-title":"Clocking in: chronobiology in rheumatoid arthritis","volume":"11","author":"Buttgereit F","year":"2015","unstructured":"Buttgereit F, Smolen JS, Coogan AN, Cajochen C. Clocking in: chronobiology in rheumatoid arthritis. Nat Rev Rheumatol. 2015, 11:349-56. 10.1038\/nrrheum.2015.31","journal-title":"Nat Rev Rheumatol"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation","volume":"140","author":"Nathan C","year":"2010","unstructured":"Nathan C, Ding A. Nonresolving inflammation. Cell. 2010, 140:871-82. 10.1016\/j.cell.2010.02.029","journal-title":"Cell"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2010.08.002","article-title":"Specialized pro-resolving lipid mediators in the inflammatory response: an update","volume":"1801","author":"Bannenberg G","year":"2010","unstructured":"Bannenberg G, Serhan CN. Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim Biophys Acta. 2010, 1801:1260-73. 10.1016\/j.bbalip.2010.08.002","journal-title":"Biochim Biophys Acta"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101637","article-title":"Exercise-induced specialized proresolving mediators stimulate AMPK phosphorylation to promote mitochondrial respiration in macrophages","volume":"66","author":"Calderin EP","year":"2022","unstructured":"Calderin EP, Zheng JJ, Boyd NL, et al.. Exercise-induced specialized proresolving mediators stimulate AMPK phosphorylation to promote mitochondrial respiration in macrophages. Mol Metab. 2022, 66:101637. 10.1016\/j.molmet.2022.101637","journal-title":"Mol Metab"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023285119","article-title":"Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the \u03b17nAChR subunit","volume":"119","author":"Caravaca AS","year":"2022","unstructured":"Caravaca AS, Gallina AL, Tarnawski L, et al.. Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the \u03b17nAChR subunit. Proc Natl Acad Sci U S A. 2022, 119:e2023285119. 10.1073\/pnas.2023285119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan CN","year":"2018","unstructured":"Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018, 128:2657-69. 10.1172\/JCI97943","journal-title":"J Clin Invest"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00400-5","article-title":"Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication","volume":"7","author":"Li C","year":"2026","unstructured":"Li C, Wang Z, Yang Y, et al.. Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication. Mol Biomed. 2026, 7:1. 10.1186\/s43556-025-00400-5","journal-title":"Mol Biomed"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan CN","year":"2014","unstructured":"Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014, 510:92-101. 10.1038\/nature13479","journal-title":"Nature"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathmechdis.3.121806.151409","article-title":"Anti-inflammatory and proresolving lipid mediators","volume":"3","author":"Serhan CN","year":"2008","unstructured":"Serhan CN, Yacoubian S, Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol. 2008, 3:279-312. 10.1146\/annurev.pathmechdis.3.121806.151409","journal-title":"Annu Rev Pathol"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.15329","article-title":"Low-grade systemic inflammation biomarkers in sedentary young healthy adults are not significantly affected by a 24-week concurrent training intervention","volume":"1547","author":"V\u00e1zquez-Lorente H","year":"2025","unstructured":"V\u00e1zquez-Lorente H, Herrera-Quintana L, Acosta FM, Amaro-Gahete FJ, Ruiz JR. Low-grade systemic inflammation biomarkers in sedentary young healthy adults are not significantly affected by a 24-week concurrent training intervention. Ann N Y Acad Sci. 2025, 1547:154-69. 10.1111\/nyas.15329","journal-title":"Ann N Y Acad Sci"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003112","article-title":"Dual delayed feedback provides sensitivity and robustness to the NF-\u03baB signaling module","volume":"9","author":"Longo DM","year":"2013","unstructured":"Longo DM, Selimkhanov J, Kearns JD, Hasty J, Hoffmann A, Tsimring LS. Dual delayed feedback provides sensitivity and robustness to the NF-\u03baB signaling module. PLoS Comput Biol. 2013, 9:e1003112. 10.1371\/journal.pcbi.1003112","journal-title":"PLoS Comput Biol"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil GS","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017, 542:177-85. 10.1038\/nature21363","journal-title":"Nature"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2010.02.069","article-title":"Effect of exercise training on chronic inflammation","volume":"411","author":"Beavers KM","year":"2010","unstructured":"Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clin Chim Acta. 2010, 411:785-93. 10.1016\/j.cca.2010.02.069","journal-title":"Clin Chim Acta"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131487","article-title":"Perfect timing: circadian rhythms, sleep, and immunity - an NIH workshop summary","volume":"5","author":"Haspel JA","year":"2020","unstructured":"Haspel JA, Anafi R, Brown MK, et al.. Perfect timing: circadian rhythms, sleep, and immunity - an NIH workshop summary. JCI Insight. 2020, 5:10.1172\/jci.insight.131487","journal-title":"JCI Insight"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S34616","article-title":"Therapeutic apheresis in autoimmune diseases","volume":"5","author":"Bambauer R","year":"2013","unstructured":"Bambauer R, Latza R, Bambauer C, Burgard D, Schiel R. Therapeutic apheresis in autoimmune diseases. Open Access Rheumatol. 2013, 5:93-103. 10.2147\/OARRR.S34616","journal-title":"Open Access Rheumatol"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01923-y","article-title":"Cellular senescence and senolytics: the path to the clinic","volume":"28","author":"Chaib S","year":"2022","unstructured":"Chaib S, Tchkonia T, Kirkland JL. Cellular senescence and senolytics: the path to the clinic. Nat Med. 2022, 28:1556-68. 10.1038\/s41591-022-01923-y","journal-title":"Nat Med"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1905136","article-title":"Effects of intermittent fasting on health, aging, and disease","volume":"381","author":"de Cabo R","year":"2019","unstructured":"de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med. 2019, 381:2541-51. 10.1056\/NEJMra1905136","journal-title":"N Engl J Med"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1605635113","article-title":"Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis","volume":"113","author":"Koopman FA","year":"2016","unstructured":"Koopman FA, Chavan SS, Miljko S, et al.. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2016, 113:8284-9. 10.1073\/pnas.1605635113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-21-0194","article-title":"Metformin as an anti-inflammatory agent: a short review","volume":"251","author":"Krist\u00f3fi R","year":"2021","unstructured":"Krist\u00f3fi R, Eriksson JW. Metformin as an anti-inflammatory agent: a short review. J Endocrinol. 2021, 251:R11-22. 10.1530\/JOE-21-0194","journal-title":"J Endocrinol"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.04.008","article-title":"Cardiovascular and other health benefits of sauna bathing: a review of the evidence","volume":"93","author":"Laukkanen JA","year":"2018","unstructured":"Laukkanen JA, Laukkanen T, Kunutsor SK. Cardiovascular and other health benefits of sauna bathing: a review of the evidence. Mayo Clin Proc. 2018, 93:1111-21. 10.1016\/j.mayocp.2018.04.008","journal-title":"Mayo Clin Proc"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S436147","article-title":"The role and mechanism of metformin in inflammatory diseases","volume":"16","author":"Lin H","year":"2023","unstructured":"Lin H, Ao H, Guo G, Liu M. The role and mechanism of metformin in inflammatory diseases. J Inflamm Res. 2023, 16:5545-64. 10.2147\/JIR.S436147","journal-title":"J Inflamm Res"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea MG","year":"2020","unstructured":"Netea MG, Dom\u00ednguez-Andr\u00e9s J, Barreiro LB, et al.. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020, 20:375-88. 10.1038\/s41577-020-0285-6","journal-title":"Nat Rev Immunol"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.3390\/medicines7070039","article-title":"The effects of Tai Chi and Qigong on immune responses: a systematic review and meta-analysis","volume":"7","author":"Oh B","year":"2020","unstructured":"Oh B, Bae K, Lamoury G, et al.. The effects of Tai Chi and Qigong on immune responses: a systematic review and meta-analysis. Medicines (Basel). 2020, 7:10.3390\/medicines7070039","journal-title":"Medicines (Basel)"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101638","article-title":"A systematic review and meta-analysis of the impact of mindfulness based interventions on heart rate variability and inflammatory markers","volume":"8","author":"R\u00e5dmark L","year":"2019","unstructured":"R\u00e5dmark L, Sidorchuk A, Osika W, Niemi M. A systematic review and meta-analysis of the impact of mindfulness based interventions on heart rate variability and inflammatory markers. J Clin Med. 2019, 8:10.3390\/jcm8101638","journal-title":"J Clin Med"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-640","article-title":"Impact of Tai Chi on CRP, TNF-alpha and IL-6 in inflammation: a systematic review and meta-analysis","volume":"10","author":"Shu C","year":"2021","unstructured":"Shu C, Feng S, Cui Q, Cheng S, Wang Y. Impact of Tai Chi on CRP, TNF-alpha and IL-6 in inflammation: a systematic review and meta-analysis. Ann Palliat Med. 2021, 10:7468-78. 10.21037\/apm-21-640","journal-title":"Ann Palliat Med"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.12701\/jyms.2022.00010","article-title":"Beneficial effects of intermittent fasting: a narrative review","volume":"40","author":"Song DK","year":"2023","unstructured":"Song DK, Kim YW. Beneficial effects of intermittent fasting: a narrative review. J Yeungnam Med Sci. 2023, 40:4-11. 10.12701\/jyms.2022.00010","journal-title":"J Yeungnam Med Sci"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-04114-7","article-title":"Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial","volume":"32","author":"Tesser JR","year":"2026","unstructured":"Tesser JR, Crowley AR, Box EJ, et al.. Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial. Nat Med. 2026, 32:369-78. 10.1038\/s41591-025-04114-7","journal-title":"Nat Med"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7310","article-title":"Epigenetics and trained immunity","volume":"29","author":"van der Heijden CD","year":"2018","unstructured":"van der Heijden CD, Noz MP, Joosten LA, Netea MG, Riksen NP, Keating ST. Epigenetics and trained immunity. Antioxid Redox Signal. 2018, 29:1023-40. 10.1089\/ars.2017.7310","journal-title":"Antioxid Redox Signal"},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.25393","article-title":"Corrigendum: Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis","volume":"39","author":"Hariyanto TI","year":"2026","unstructured":"Hariyanto TI, Vatvani AD, Patel P, Yanto TA. Corrigendum: Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Korean J Pain. 2026, 39:147-9. 10.3344\/kjp.25393","journal-title":"Korean J Pain"},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.21053\/ceo.2024.00286","article-title":"Reprogramming macrophage phenotypes with photobiomodulation for improved inflammation control in ENT organ tissues","volume":"18","author":"Woo K","year":"2025","unstructured":"Woo K, Kim YS, Abueva C, Woo SH. Reprogramming macrophage phenotypes with photobiomodulation for improved inflammation control in ENT organ tissues. Clin Exp Otorhinolaryngol. 2025, 18:1-13. 10.21053\/ceo.2024.00286","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1143548","article-title":"Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials","volume":"14","author":"Zheng Y","year":"2023","unstructured":"Zheng Y, Zhang Z, Tang P, et al.. Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials. Front Immunol. 2023, 14:1143548. 10.3389\/fimmu.2023.1143548","journal-title":"Front Immunol"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00061","article-title":"The continuum of aging and age-related diseases: common mechanisms but different rates","volume":"5","author":"Franceschi C","year":"2018","unstructured":"Franceschi C, Garagnani P, Morsiani C, et al.. The continuum of aging and age-related diseases: common mechanisms but different rates. Front Med (Lausanne). 2018, 5:61. 10.3389\/fmed.2018.00061","journal-title":"Front Med (Lausanne)"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn C","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023, 186:243-78. 10.1016\/j.cell.2022.11.001","journal-title":"Cell"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn C","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013, 153:1194-217. 10.1016\/j.cell.2013.05.039","journal-title":"Cell"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.11.001","article-title":"Meta-hallmarks of aging and cancer","volume":"35","author":"L\u00f3pez-Ot\u00edn C","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Pietrocola F, Roiz-Valle D, Galluzzi L, Kroemer G. Meta-hallmarks of aging and cancer. Cell Metab. 2023, 35:12-35. 10.1016\/j.cmet.2022.11.001","journal-title":"Cell Metab"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-020-00247-4","article-title":"Association of inflammatory mediators with frailty status in older adults: results from a systematic review and meta-analysis","volume":"42","author":"Marcos-P\u00e9rez D","year":"2020","unstructured":"Marcos-P\u00e9rez D, S\u00e1nchez-Flores M, Proietti S, et al.. Association of inflammatory mediators with frailty status in older adults: results from a systematic review and meta-analysis. Geroscience. 2020, 42:1451-73. 10.1007\/s11357-020-00247-4","journal-title":"Geroscience"},{"key":"ref184","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2016.08.006","article-title":"Inflammation and frailty in the elderly: a systematic review and meta-analysis","volume":"31","author":"Soysal P","year":"2016","unstructured":"Soysal P, Stubbs B, Lucato P, et al.. Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev. 2016, 31:1-8. 10.1016\/j.arr.2016.08.006","journal-title":"Ageing Res Rev"},{"key":"ref185","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-021-02022-7","article-title":"Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies","volume":"34","author":"Xu Y","year":"2022","unstructured":"Xu Y, Wang M, Chen D, Jiang X, Xiong Z. Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies. Aging Clin Exp Res. 2022, 34:971-87. 10.1007\/s40520-021-02022-7","journal-title":"Aging Clin Exp Res"},{"key":"ref186","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2007.06.006","article-title":"Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients","volume":"8","author":"Staud R","year":"2007","unstructured":"Staud R, Robinson ME, Price DD. Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J Pain. 2007, 8:893-901. 10.1016\/j.jpain.2007.06.006","journal-title":"J Pain"},{"key":"ref187","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.05654","article-title":"Mechanisms of desensitization of the adrenocorticotropin response to arginine vasopressin in ovine anterior pituitary cells","volume":"184","author":"Hassan A","year":"2005","unstructured":"Hassan A, Mason D. Mechanisms of desensitization of the adrenocorticotropin response to arginine vasopressin in ovine anterior pituitary cells. J Endocrinol. 2005, 184:29-40. 10.1677\/joe.1.05654","journal-title":"J Endocrinol"},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.123.000831","article-title":"Adrenoceptor desensitization: current understanding of mechanisms","volume":"76","author":"Maaliki D","year":"2024","unstructured":"Maaliki D, Jaffa AA, Nasser S, Sahebkar A, Eid AH. Adrenoceptor desensitization: current understanding of mechanisms. Pharmacol Rev. 2024, 76:358-87. 10.1124\/pharmrev.123.000831","journal-title":"Pharmacol Rev"},{"key":"ref189","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2017.01.024","article-title":"GPCR desensitization: acute and prolonged phases","volume":"41","author":"Rajagopal S","year":"2018","unstructured":"Rajagopal S, Shenoy SK. GPCR desensitization: acute and prolonged phases. Cell Signal. 2018, 41:9-16. 10.1016\/j.cellsig.2017.01.024","journal-title":"Cell Signal"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/512118-recovery-primed-stimulation-a-proposed-framework-for-controlled-triggering-of-healing-related-physiology-in-low-grade-chronic-inflammation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:59:26Z","timestamp":1786445966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/512118-recovery-primed-stimulation-a-proposed-framework-for-controlled-triggering-of-healing-related-physiology-in-low-grade-chronic-inflammation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":189,"URL":"https:\/\/doi.org\/10.7759\/cureus.114334","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}